Clinical Trial Update: Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

View source ↗

Summary

This observational study investigates the sensitivity of neoadjuvant immunotherapy in patients with early-stage triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Shandong University | Conditions: Triple Negative Breast Cancer, Neoadjuvant Immunotherapy | Status: NOT_YET_RECRUITING